Magazine Article | April 1, 2022

3 Essentials For A Fit-For-Purpose Compliance Strategy In Decentralized Pharma

Source: Life Science Leader

By Penelope Przekop, MSQA , RQA P-GCP, and Valerie Przekop

Outsourcing and technology have morphed our industry into a new decentralized model. Now, each sponsor must carefully develop an ongoing compliance strategy considering its unique business model and its influence on the drug development journey. Strategies are needed to design quality management systems (QMSs) that can expand and pivot in tandem with corporate and clinical development.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader